🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Surrozen, Inc.

SRZN Healthcare
$23.96 +$0.23 (0.97%)
Market Cap: $281.62 M
Gurus Holding
3
Popularity Rank
#3153
% of Shares Held
5.84%
Net Activity (Q2 2026)
+$16.54 M

Guru Ownership Trend

Guru Analysis for Surrozen, Inc. (SRZN)

Surrozen, Inc. (SRZN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.45 M.

Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $16.54 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 74.8%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$17.49 M
Total Buy Value
New Buys 2
Additions 0
-$953,713.51
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Surrozen, Inc. (SRZN)

Major holders include Steven Cohen ($17.24 M), Renaissance Technologies (RenTech) ($321,105), Ken Fisher ($255,348). According to the latest reported data, 3 tracked investment managers collectively hold approximately 686,486 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $16.54 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited SRZN. The total reported sell value was $953,713.51.

Yes, 2 managers opened new positions in SRZN, and 0 increased their existing holdings. The total reported buy value was $17.49 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% New Buy 664,272 $17.24 M Q2 2026
0.00% Reduce -74.8% 12,374 $321,105 Q2 2026
0.00% New Buy 9,840 $255,348 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form